This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2022-2023.
Company Filing History:
Years Active: 2022-2023
Title: Sanjiv Sur: Innovator in Recombinant Therapeutics
Introduction
Sanjiv Sur is a prominent inventor based in Galveston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods and compositions. With a total of 2 patents, his work focuses on innovative solutions for medical treatments.
Latest Patents
Sanjiv Sur's latest patents include groundbreaking research in two key areas. The first patent, titled "Methods and compositions related to recombinant NEIL2," is directed towards NEIL2 compositions and methods for using these compositions to treat subjects in need of such treatment. The second patent, "BRD4 inhibitor treatment of IgE-mediated diseases," outlines methods for utilizing BRD4 inhibitors to treat IgE-mediated diseases, showcasing his commitment to advancing medical science.
Career Highlights
Sanjiv Sur is affiliated with The University of Texas System, where he continues to engage in innovative research. His work has garnered attention for its potential impact on therapeutic practices and patient care.
Collaborations
Throughout his career, Sanjiv has collaborated with notable colleagues, including Tapas Hazra and Ashok K Chopra. These partnerships have contributed to the advancement of his research and the development of new therapeutic strategies.
Conclusion
Sanjiv Sur's contributions to biotechnology through his patents and research exemplify his dedication to improving medical treatments. His innovative work continues to inspire advancements in the field, making a significant impact on healthcare.